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Background: To report the indications and clinical outcomes of all capsular tension ring (CTR) 
implantations in a large series of consecutive cataract surgeries during a ﬁ  ve year interval in a 
university eye hospital.
Methods: The study was designed as a restrospective analysis of a consecutive series of 
9528 cataract surgeries. The records were checked for cases in which a CTR was implanted. 
The indications and clinical outcomes of CTR implantation were documented and an evaluation 
of posterior chamber intraocular lens (PCIOL) insertion, position, and centration.
Results: In this series, a CTR was implanted in 69 eyes of 67 patients. The indications were 
advanced or mature cataract in 40, post-traumatic cataract in 23, pseudoexfoliation syndrome 
in 4 and subluxated lens in 2 eyes. PCIOL implantation in the capsular bag was possible in 
61 (90%) of these 69 eyes. In 5 (7%) additional eyes, PCIOL implantation in the ciliary sulcus 
was accomplished. In one eye (1%) no IOL implantation was performed because of high myopia. 
In only two of 69 eyes (2%), an anterior chamber intraocular lens had to be inserted despite prior 
CTR implantation. In 5 eyes (5%), a slight dislocation of the IOL was noted postoperatively, but 
none of these patients complained of visually relevant symptoms (eg, monocular diplopia).
Conclusions: According to our experience CTRs are used very infrequently (0.7%), but remain 
useful in cataract surgeries with difﬁ  cult preoperative or intraoperative conditions. If zonulolysis 
is less than two quadrants in extent, implantation of a PCIOL was possible in 98% of cases. 
Implantation of CTRs with special designs may have additional advantages (eg, inhibition of 
posterior capsule opacity) and warrant further investigation.
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Introduction
The capsular tension ring (CTR) was ﬁ  rst described in 1991 by Hara and coauthors 
(1991). They named it an “equator ring”, designed to maintain the circular contour 
of the capsular bag after lens removal during cataract surgery. However, their ﬂ  ex-
ible silicon ring did not adapt to the different capsular bag sizes. In 1993, a different 
design was introduced allowing for an individual expansion and therefore being 
applicable for eyes with different dimensions (Nagamoto 2001). Since then, the ﬁ  rst 
polymethylmethacrylate (PMMA) open capsular ring was produced by Morcher® 
(Stuttgart, Germany). Soon others (Ophtec®, Ioltech®, Acrimed®, etc.) began to pro-
duce similar devices. Nowadays, various designs have been developed for average 
individuals (Morcher® type 14, 10.0 mm closed diameter), highly myopic patients 
(Morcher® type 14A, 12.0 mm), and for children (Morcher® type 1C, 9.00 mm). In 
addition special CTRs were designed for cases with severe zonular dehiscence and 
an additional ﬁ  xation hook for scleral ﬁ  xation (Cionni and Osher 1995, 1998; Lam 
et al 2000; Ahmed and Crandall 2001). Coloboma shield CTRs and multisegmental 
coloboma rings have been suggested for large sector iris defects or congenital aniridia. 
Nishi and Menapace (1998, 2001) recently developed a square edged CTR to prevent 
posterior capsule opaciﬁ  cation (Dick and Schwenn 1999).Clinical Ophthalmology 2007:1(1) 66
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Originally the CTR was designed to stabilize the capsule 
in eyes with zonular weakness or dehiscence (Gimbel et al 
1997; Sun and Gimbel 1998; Gimbel and Sun 2002), intra-
ocular lens (IOL)-luxation (Groessi and Anderson 1998; 
Dietlein et al 2000), pseudoexfoliation syndrome (Menapace 
et al 2000; Bayraktar et al 2001), and highly myopic eyes 
not receiving a posterior chamber intraocular lens (PCIOL). 
In past years the CTR has been widely used throughout Eu-
rope, but this far was not FDA-approved in the USA. The 
purpose of our study was to evaluate the frequency, indica-
tions, and clinical outcome of CTR implantation in a large 
series of consecutive cataract surgical cases performed during 
the years 1997 through 2001 in our institution.
Patients and methods
Surgical technique
After preoperative dilation of the pupil the conjunctival sac 
was ﬂ  ushed with 10 ml 10% povidone iodine rinsing solution. 
Superior, either a sclerocorneal or a clear corneal incision, 
was created using a diamond blade followed by a 2.75 mm 
steel keratome (Alcon, Fort Worth, TX). Further two 1.2 mm 
clear corneal incisions were performed with a 15° keratome 
(Alcon) and the anterior chamber was expanded with a 
viscoelastic substance (Healon, AMO, Santa Ana, CA). For 
cataract surgery of mature cataracts, Trypan blue (vision blue, 
DORC, Netherlands) was used to enhance visualization of 
the anterior lens capsule. Capsulotomy was performed using 
a 25 gauge needle. After hydrodissection cataract extraction 
was performed using the divide and conquer technique. The 
Megatron S3 (Geuder, Heidelberg, Germany) phacoemulsi-
ﬁ  cation unit was used, with an ultrasound power set 50% to 
100% and a phaco tip angled at 30 degrees. 
Chart review 
We retrospectively reviewed the cataract database of the 
Department of Ophthalmology, Ludwig-Maximilians-
University, Munich for records indicating implantation 
of a CTR. Since the ﬁ  rst documented implantation of 
a CTR in our institution, all subsequent records were 
screened for indication of a CTR implantation, and subse-
quently clinical outcome was analyzed. In all cases a CTR 
Morcher®, Type 14 (open diameter 12.3 mm, PMMA) was 
used (Figure 1). Speciﬁ  c indications included zonulolysis 
or posterior capsular rupture. In case of a zonulolysis, 
exogenous (trauma, prior pars-plana-vitrectomy with 
silicone oil tamponade), or endogenous (pseudoexfoliation 
syndrome, Marfan syndrome) causes were distinguished. 
The decision to insert the CTR was made intraoperatively 
when loose zonules where apparent during capsulorhexis 
or phacoemulsiﬁ  cation, or when a posterior capsular rup-
ture occurred. In case of a posterior capsular rupture, an 
anterior vitrectomy was performed. Our surgeons mainly 
used phacoemulsiﬁ  cation to extract the cataract; a planned 
extracapsular cataract extraction was performed only twice. 
In all cases, the CTR was inserted with a special shooter. 
If accidental displacement into the vitreous occurred during 
the procedure, the CTR was removed. 
The main clinical outcome measurement was a possible 
PCIOL-implantation with differentiation between implan-
tation in the capsular bag or the ciliary sulcus. In addition, 
the position of the intraocular lens was noted. In case of 
IOL subluxation or dislocation, the clinical symptoms (eg, 
monocular double vision) were evaluated. 
Results
During the period of review of 5 years, 9528 cataract surger-
ies were performed in our department. In 69 of these surgeries 
Figure 1 Morcher® type 14 CTR (open diameter 12.5 mm)(down) and IOL (up).
Abbreviations: CTR, capsular tension ring, IOL, intraocular lens.Clinical Ophthalmology 2007:1(1) 67
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(67 patients) a CTR was implanted (Table 1). Among these 
patients 37 (55%) were male and 30 (45%) were female. The 
mean age was 62 years with a range from 22 to 101 years. 
The range of follow up was between one and three years.
The indications for CTR implantation were as follows: 
In 35 eyes, a zonular dehiscence or weakness of different 
origin was observed before surgery, with exogenous causes 
of zonulolysis being evident in 29 eyes (23 with prior 
trauma and 6 with history of pars plana vitrectomy and 
silicone oil tamponade) and endogenous zonulolysis being 
apparent in 6 eyes; speciﬁ  cally, 4 eyes (6%) with pseudo-
exfoliation syndrome and 2 eyes (3%) of one patient with 
Marfan syndrome. In 23 eyes, a zonular rupture occured 
during cataract surgery itself. In the remaining 11 eyes, 
no underlying predisposition could be identiﬁ  ed before 
surgery. Most likely in these cases the zonulolysis occured 
during the procedure. An advanced or mature cataract was 
present in 40 eyes (58%). 
All in all, implantation of a CTR was chosen because of 
zonular dialysis in 61 eyes (88%), rupture of the posterior 
capsule in one eye (2%), or both zonular dialysis and rupture 
of the posterior capsule in 7 eyes (10%).
In 67 eyes (98%), an implantation of a posterior chamber 
intraocular lens (PCIOL) was performed without complica-
tion following the implantation of a CTR. In 61 cases (90%), 
an implantation into the capsular bag could be accomplished, 
whereas in 5 eyes (7%), the PCIOL had to be implanted into 
the ciliary sulcus. In one eye (1%) no IOL implantation was 
performed because of high myopia.
Thus, in only two of 69 eyes (2%) an IOL implantation 
into the capsular bag or ciliary sulcus was not possible despite 
prior CTR insertion: In one eye IOL implantation into cap-
sular bag or ciliary sulcus was not possible due to extensive 
zonulolysis. In the second case an implanted PCIOL and the 
CTR dislocated into the vitreous 5 days after surgery and 
had to be removed. Both of these eyes received an anterior 
chamber IOL.
The PCIOL remained in a centered position in 61 eyes 
(92%) whereas in 5 eyes (8%) a dislocation of the IOL was 
observed during slit lamp biomicroscopy. However none of 
these patients complained of any symptoms such as mon-
ocular diplopia and the decentration was stable and did not 
progress further during follow up.
Discussion
The present study was performed to address two subjects: 
First, to evaluate the frequency of CTR implantation in a 
large consecutive series of cataract surgeries. Second, to 
investigate whether an anatomically reasonable outcome 
could be reached by the insertion of a CTR in a variety of 
complicated cataract surgeries. Final visual outcome was not 
investigated in our study as the group of patients investigated 
was rather heterogenous with a large spectrum of additional 
diseases such as macular degeneration and diabetic retinopa-
thy that would have signiﬁ  cantly biased any evaluation of 
functional outcome. Therefore, the present study aimed at 
an anatomical or morphological evaluation of the surgical 
results and focused on the applicability of CTR implantation 
during cataract surgery.
Since the ﬁ  rst insertion of a CTR in our institution, 9528 
cataract surgeries have been performed during the following 
period of 5 years. Despite the fact that predominantly severe 
forms of cataracts and complicated cases are relatively fre-
quent in our tertiary care center university setting, only rela-
tively few cases (0.7%) required the implantation of a CTR, 
probably because the surgeries were done by experienced an-
terior segment surgeons. The predominant indication for CTR 
implantation was determined by an unstable intraoperative 
condition either caused by zonular dehiscence or weakness 
and/or posterior capsular rupture, or by different conditions 
including mature cataract (40 eyes, 58%), traumatic cataract 
(23 eyes, 33%), pseudoexfoliation syndrome (4 eyes, 6%), 
and subluxated lenses due to Marfan syndrome (2 eyes, 3%). 
The indications for CTR implantation are in line with other 
Table 1 Patients with CTR implantation: pre- and post-operative characteristics
Pre-op characteristics      Post-op characteristics
Mean age    62    CTR and IOL  Capsular bag  61
Sex   Male  37      Sulcus  5
 Female  30
Diagnosis  Mature cataract  40    CTR only (no IOL planned)    1
 Traumatic  cataract  23
  Subluxated lens  2    No IOL despite CTR    2
 PEX  4
Abbreviations: CTR, capsular tension ring, IOL, intraocular lens; PEX, pseudoexfoliation syndrome. Clinical Ophthalmology 2007:1(1) 68
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authors who also used the CTR in eyes with intraoperative 
signs for loose or broken zonules like decentration of the 
crystalline lens, movement of the lens during capsulorhexis, 
phacoemulsiﬁ  cation or irrigation/aspiration (Gimbel et al 
1997; Sun and Gimbel 1998; Menapace et al 2000; Lee 
et al 2001, 2002; Gimbel and Sun 2002). Like other authors 
(Menapace et al 2000; Gimbel and Sun 2002), our surgeons 
inserted the CTR as soon as zonular weekness was seen in-
traoperatively, for example before or after hydrodissection 
and prior to phacoemulsiﬁ  cation or after complete phaco-
emulsiﬁ  cation and prior to PCIOL insertion.
The PCIOL was successfully implanted in almost all 
cases (97%), with an implantation in the capsular bag being 
possible in the majority of cases (91%). Only in two cases no 
permanent implantation of an PCIOL was possible despite 
prior insertion of a CTR; in one of these eyes a dislocation 
of both the CTR and the PCIOL occurred due to extended 
zonular dehiscence and led to explantation of both implants 
(Table 1). 
In our series one highly myopic eye was left without 
IOL. The CTR helps in these cases to maintain the circular 
contour of the capsular bag and the shape of the continuous 
circular capsulorhexis (Sun and Gimbel 1998). Thus, folds 
in the posterior capsular bag are minimized.
The only postoperative complication found in our series 
was minor PCIOL decentration noted biomicroscopically 
during follow up, but no subjective visual symptoms were 
noted by the patients. Because this was a retrospective chart 
review we were unable to determine whether the same results 
would have been reached without CTR implantation.
At the moment several clinical studies are also attempt-
ing to investigate if routine CTR insertion is reasonable to 
prevent capsular shrinkage and posterior capsule opaciﬁ  ca-
tion (Strenn et al 1997; Nishi et al 1998, 2001; Dick and 
Schwenn 1999; Faschinger and Eckhardt 1999; Sudhir and 
Rao 2001; Waheed et al 2001). Since the invention of the 
capsular tension ring in 1991, many authors have reported 
its advantages in anterior segment surgery. Our results in this 
large series over a relatively long period of time conﬁ  rm that 
CTR implantation is a useful device for cataract surgery in 
selected cases with difﬁ  cult pre- or intraoperative conditions 
(Figure 2). 
A weakness of the present study is the retrospective nature 
and the lack of a control group. Obviously, only a prospective 
randomized study could further elucidate whether the same 
clincial outcome (eg, possibility of PCIOL implantation) 
could be achieved without prior implantation of a CTR. 
However, the following aspects should be considered in this 
context: First, based on our study with a frequency of CTR 
implantation of 0.7%, the number of cataract cases included 
will have to be very large to achieve statistical power. Second, 
the decision whether to implant a CTR or not is usually made 
during surgery; this approach interferes with a prospective 
randomized study setting. Third, patients would have to 
give their informed consent prior to surgery allowing for 
the randomized (non-) use of a CTR even in the event of 
Figure 2 UBM ﬁ  ndings after CTR and IOL insertion (intraoperative zonulolysis over 4 clock hours) (Fries et al 1998). 
Notes: CTR (1), haptic of IOL (2), and IOL (3).
Abbreviations: CTR, capsular tension ring, IOL, intraocular lens; UBM, ultrasound biomicroscopy.Clinical Ophthalmology 2007:1(1) 69
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complicated surgery. In the absence of such a randomized 
study to the best of our knowledge our experience represents 
the largest series of consecutive cataract surgeries that was 
evaluated for implantation of a CTR.
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